Residual Drug in Transdermal and Related Drug Delivery Systems: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 17, 2011
April 23, 2020
54698fcf-db58-4dd4-ac3a-81992e898cae
Related Documents
ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers
Guidance DocumentMay 15, 2014Center for Drug Evaluation and Research
ANDAs: Stability Testing of Drug Substances and Products
Guidance DocumentJune 20, 2013Center for Drug Evaluation and Research
Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation
Guidance DocumentMarch 13, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox